Adjust Font Sizing:

New Narcolepsy Clinical Trial

May 11th, 2020

If you have narcolepsy with cataplexy, you may be able to help with research to develop a new treatment option.

What is the purpose of the Sparkle 1501 Study?
The SPARKLE 1501 Study is testing an investigational drug in people with narcolepsy with cataplexy. The main purpose of the study is to look at how safe and tolerable the investigational drug is and how it may affect a person’s narcolepsy symptoms.

Study participation eligibility
You may qualify if you:

You may qualify to participate if you:
– Are 18–65 years old
– Have been diagnosed with narcolepsy with cataplexy (also known as narcolepsy type 1)
– Are willing to stop taking narcolepsy medications during study participation
– Are willing to stop smoking and give up all nicotine use while you are at the study clinic, including each time you stay overnight
– Meet additional requirements as determined by a screening process

To see if you are a potential candidate, answer this online prescreening questionnaire. Depending on your answers, you may be referred to a study clinic for additional screening.

Travel support and compensation for study participation may be available. A study doctor and staff can explain to you in greater detail other requirements and eligibility criteria you would have to meet in order to participate in the study.

To learn more about the Sparkle 1501 Study and to see if you may qualify, visit See this flyer for more information.

# # #
Date Created: May 11th, 2020
Last Updated: May 12th, 2020

Do NOT follow this link or you will be banned from the site!